{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:50:23Z","timestamp":1787021423117,"version":"build-2736575974"},"reference-count":46,"publisher":"Japanese Circulation Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2025,12,25]]},"DOI":"10.1253\/circj.cj-24-0888","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T22:07:43Z","timestamp":1758319663000},"page":"88-95","source":"Crossref","is-referenced-by-count":7,"title":["Clinical Implications of Non-Sustained Ventricular Tachycardia in the Indication for Primary Prevention With an Implantable Cardioverter Defibrillator\u3000\u2015 Subanalysis From the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE) \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Kohei","family":"Ishibashi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Oka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Wakamiya","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenzaburo","family":"Nakajima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Kamakura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nagase","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Aiba","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"},{"name":"Department of Advanced Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kusano","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Aonuma","sequence":"additional","affiliation":[{"name":"Cardiovascular Department, Mito Saiseikai Genreral Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the HINODE Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. <i>N Engl J Med<\/i> 1996; 335: 1933\u20131940, doi:10.1056\/NEJM199612263352601.","DOI":"10.1056\/NEJM199612263352601"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. <i>N Engl J Med<\/i> 2002; 346: 877\u2013883, doi:10.1056\/NEJMoa013474.","DOI":"10.1056\/NEJMoa013474"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. <i>N Engl J Med<\/i> 2005; 352: 225\u2013237, doi:10.1056\/NEJMoa043399.","DOI":"10.1056\/NEJMoa043399"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, et al. Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: An extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. <i>Circulation<\/i> 2010; 122: 1265\u20131271, doi:10.1161\/CIRCULATIONAHA.110.940148.","DOI":"10.1161\/CIRCULATIONAHA.110.940148"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Desai AS, Fang JC, Maisel WH, Baughman KL. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: A meta-analysis of randomized controlled trials. <i>JAMA<\/i> 2004; 292: 2874\u20132879, doi:10.1001\/jama.292.23.2874.","DOI":"10.1001\/jama.292.23.2874"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Golwala H, Bajaj NS, Arora G, Arora P. Implantable cardioverter-defibrillator for nonischemic cardiomyopathy: An updated meta-analysis. <i>Circulation<\/i> 2017; 135: 201\u2013203, doi:10.1161\/CIRCULATIONAHA.116.026056.","DOI":"10.1161\/CIRCULATIONAHA.116.026056"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Barakat AF, Saad M, Elgendy AY, Mentias A, Abuzaid A, Mahmoud AN, et al. Primary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: A meta-analysis of randomised controlled trials. <i>BMJ Open<\/i> 2017; 7: e016352, doi:10.1136\/bmjopen-2017-016352.","DOI":"10.1136\/bmjopen-2017-016352"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Connolly SJ, Gent M, Roberts RS, Dorian P, Roy D, Sheldon RS, et al. Canadian Implantable Defibrillator Study (CIDS): A randomized trial of the implantable cardioverter defibrillator against amiodarone. <i>Circulation<\/i> 2000; 101: 1297\u20131302, doi:10.1161\/01.cir.101.11.1297.","DOI":"10.1161\/01.CIR.101.11.1297"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. <i>N Engl J Med<\/i> 1997; 337: 1576\u20131583, doi:10.1056\/NEJM199711273372202.","DOI":"10.1056\/NEJM199711273372202"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Kuck KH, Cappato R, Siebels J, Ruppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: The Cardiac Arrest Study Hamburg (CASH). <i>Circulation<\/i> 2000; 102: 748\u2013754, doi:10.1161\/01.cir.102.7.748.","DOI":"10.1161\/01.CIR.102.7.748"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, et al. Corrigendum: JCS\/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. <i>Circ J<\/i> 2021; 85: 1692\u20131700, doi:10.1253\/circj.CJ-66-0196.","DOI":"10.1253\/circj.CJ-66-0196"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA, et al. 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. <i>Eur Heart J<\/i> 2022; 43: 3997\u20134126, doi:10.1093\/eurheartj\/ehac262.","DOI":"10.1093\/eurheartj\/ehac262"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. <i>J Am Coll Cardiol<\/i> 2018; 72: e91\u2013e220, doi:10.1016\/j.jacc.2017.10.054.","DOI":"10.1016\/j.jacc.2017.10.054"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Scirica BM, Braunwald E, Belardinelli L, Hedgepeth CM, Spinar J, Wang W, et al. Relationship between nonsustained ventricular tachycardia after non-ST-elevation acute coronary syndrome and sudden cardiac death: Observations from the Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-elevation Acute Coronary Syndrome\u2013Thrombolysis In Myocardial Infarction 36 (MERLIN-TIMI 36) randomized controlled trial. <i>Circulation<\/i> 2010; 122: 455\u2013462, doi:10.1161\/CIRCULATIONAHA.110.937136.","DOI":"10.1161\/CIRCULATIONAHA.110.937136"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Cheema AN, Sheu K, Parker M, Kadish AH, Goldberger JJ. Nonsustained ventricular tachycardia in the setting of acute myocardial infarction: Tachycardia characteristics and their prognostic implications. <i>Circulation<\/i> 1998; 98: 2030\u20132036, doi:10.1161\/01.cir.98.19.2030.","DOI":"10.1161\/01.CIR.98.19.2030"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Mittal S, Aktas MK, Moss AJ, McNitt S, Kutyifa V, Steinberg JS, et al. The impact of nonsustained ventricular tachycardia on reverse remodeling, heart failure, and treated ventricular tachyarrhythmias in MADIT-CRT. <i>J Cardiovasc Electrophysiol<\/i> 2014; 25: 1082\u20131087, doi:10.1111\/jce.12456.","DOI":"10.1111\/jce.12456"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Hohnloser SH, Klingenheben T, Zabel M, Schopperl M, Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. <i>J Am Coll Cardiol<\/i> 1999; 33: 1895\u20131902, doi:10.1016\/s0735-1097(99)00108-4.","DOI":"10.1016\/S0735-1097(99)00108-4"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis G, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. <i>Circulation<\/i> 2000; 101: 40\u201346, doi:10.1161\/01.cir.101.1.40.","DOI":"10.1161\/01.CIR.101.1.40"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. <i>Circulation<\/i> 1993; 87: 312\u2013322, doi:10.1161\/01.cir.87.2.312.","DOI":"10.1161\/01.CIR.87.2.312"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Bloch Thomsen PE, Jons C, Raatikainen MJ, Moerch Joergensen R, Hartikainen J, Virtanen V, et al. Long-term recording of cardiac arrhythmias with an implantable cardiac monitor in patients with reduced ejection fraction after acute myocardial infarction: The Cardiac Arrhythmias and Risk Stratification After Acute Myocardial Infarction (CARISMA) study. <i>Circulation<\/i> 2010; 122: 1258\u20131264, doi:10.1161\/CIRCULATIONAHA.109.902148.","DOI":"10.1161\/CIRCULATIONAHA.109.902148"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Satake H, Fukuda K, Sakata Y, Miyata S, Nakano M, Kondo M, et al. Current status of primary prevention of sudden cardiac death with implantable cardioverter defibrillator in patients with chronic heart failure: A report from the CHART-2 Study. <i>Circ J<\/i> 2015; 79: 381\u2013390, doi:10.1253\/circj.CJ-14-0925.","DOI":"10.1253\/circj.CJ-14-0925"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Chia YMF, Teng TK, Tan ESJ, Tay WT, Richards AM, Chin CWL, et al. Disparity between indications for and utilization of implantable cardioverter defibrillators in Asian patients with heart failure. <i>Circ Cardiovasc Qual Outcomes<\/i> 2017; 10: e003651, doi:10.1161\/CIRCOUTCOMES.116.003651.","DOI":"10.1161\/CIRCOUTCOMES.116.003651"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Tanno K, Miyoshi F, Watanabe N, Minoura Y, Kawamura M, Ryu S, et al. Are the MADIT II criteria for ICD implantation appropriate for Japanese patients? <i>Circ J<\/i> 2005; 69: 19\u201322, doi:10.1253\/circj.69.19.","DOI":"10.1253\/circj.69.19"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Shiga T, Hagiwara N, Ogawa H, Takagi A, Nagashima M, Yamauchi T, et al. Sudden cardiac death and left ventricular ejection fraction during long-term follow-up after acute myocardial infarction in the primary percutaneous coronary intervention era: Results from the HIJAMI-II registry. <i>Heart<\/i> 2009; 95: 216\u2013220, doi:10.1136\/hrt.2008.145243.","DOI":"10.1136\/hrt.2008.145243"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Yamasaki H, Ando K, Ikeda T, Mitsuhashi T, Murohara T, Nishii N, et al. Rationale and design of the HINODE study: Heart Failure Indication and Sudden Cardiac Death Prevention Trial Japan. <i>J Arrhythm<\/i> 2021; 37: 1031\u20131037, doi:10.1002\/joa3.12577.","DOI":"10.1002\/joa3.12577"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Aonuma K, Ando K, Kusano K, Asai T, Inoue K, Inamura Y, et al. Primary results from the Japanese Heart Failure and Sudden Cardiac Death Prevention Trial (HINODE). <i>ESC Heart Fail<\/i> 2022; 9: 1584\u20131596, doi:10.1002\/ehf2.13901.","DOI":"10.1002\/ehf2.13901"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. <i>N Engl J Med<\/i> 2009; 361: 1329\u20131338, doi:10.1056\/NEJMoa0906431.","DOI":"10.1056\/NEJMoa0906431"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. An Y, Ando K, Soga Y, Nomura A, Nagashima M, Hayashi K, et al. Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria. <i>J Arrhythm<\/i> 2017; 33: 17\u201322, doi:10.1016\/j.joa.2016.01.012.","DOI":"10.1016\/j.joa.2016.01.012"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Biffi M, Pelargonio G, Havlicek A. Pacemaker programming, physiologic pacing settings, and clinical outcomes in real-world practice: Results from the OPTI-MIND clinical study. <i>J Innov Card Rhythm Manag<\/i> 2016; 7: 2229\u20132237.","DOI":"10.19102\/icrm.2016.070101"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. <i>J Am Coll Cardiol<\/i> 2008; 51: 288\u2013296, doi:10.1016\/j.jacc.2007.08.058.","DOI":"10.1016\/j.jacc.2007.08.058"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Junttila MJ, Barthel P, Myerburg RJ, Makikallio TH, Bauer A, Ulm K, et al. Sudden cardiac death after myocardial infarction in patients with type 2 diabetes. <i>Heart Rhythm<\/i> 2010; 7: 1396\u20131403, doi:10.1016\/j.hrthm.2010.07.031.","DOI":"10.1016\/j.hrthm.2010.07.031"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Yap J, Tay WT, Teng TK, Anand I, Richards AM, Ling LH, et al. Association of diabetes mellitus on cardiac remodeling, quality of life, and clinical outcomes in heart failure with reduced and preserved ejection fraction. <i>J Am Heart Assoc<\/i> 2019; 8: e013114, doi:10.1161\/JAHA.119.013114.","DOI":"10.1161\/JAHA.119.013114"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Schuger C, Daubert JP, Brown MW, Cannom D, Estes NA 3rd, Hall WJ, et al. Multicenter Automatic Defibrillator Implantation Trial: Reduce Inappropriate Therapy (MADIT-RIT): Background, rationale, and clinical protocol. <i>Ann Noninvasive Electrocardiol<\/i> 2012; 17: 176\u2013185, doi:10.1111\/j.1542-474X.2012.00531.x.","DOI":"10.1111\/j.1542-474X.2012.00531.x"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Gold MR, Knops R, Burke MC, Lambiase PD, Russo AM, Bongiorni MG, et al. The design of the Understanding Outcomes with the S-ICD in Primary Prevention Patients with Low EF Study (UNTOUCHED). <i>Pacing Clin Electrophysiol<\/i> 2017; 40: 1\u20138, doi:10.1111\/pace.12994.","DOI":"10.1111\/pace.12994"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Takase B, Ikeda T, Shimizu W, Abe H, Aiba T, Chinushi M, et al. JCS\/JHRS 2022 guideline on diagnosis and risk assessment of arrhythmia. <i>Circ J<\/i> 2024; 88: 1509\u20131595, doi:10.1253\/circj.CJ-22-0827.","DOI":"10.1253\/circj.CJ-22-0827"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Younis A, Goldberger JJ, Kutyifa V, Zareba W, Polonsky B, Klein H, et al. Predicted benefit of an implantable cardioverter-defibrillator: The MADIT-ICD benefit score. <i>Eur Heart J<\/i> 2021; 42: 1676\u20131684, doi:10.1093\/eurheartj\/ehaa1057.","DOI":"10.1093\/eurheartj\/ehaa1057"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Sato H, Noda T, Ito T, Yamamoto N, Chiba T, Hasebe Y, et al. Optimizing patient selection for cardiac resynchronization therapy with or without defibrillator in a multicenter study of Japanese patients: Assessment of the MADIT-ICD benefit score. <i>Circ J<\/i> 2025; 89: 224\u2013233, doi:10.1253\/circj.CJ-24-0329.","DOI":"10.1253\/circj.CJ-24-0329"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Tateishi R, Shimizu M, Suzuki M, Sakai E, Shimizu A, Shimada H, et al. Machine learning-based clustering using a 12-lead electrocardiogram in patients with a implantable cardioverter defibrillator to identify future ventricular arrhythmia. <i>Circ J<\/i> 2025; 89: 240\u2013250, doi:10.1253\/circj.CJ-24-0269.","DOI":"10.1253\/circj.CJ-24-0269"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Makimoto H, Zielke S, Clasen L, Lin T, Gerguri S, Muller P, et al. Clinical significance of precedent asymptomatic non-sustained ventricular tachycardias on subsequent ICD interventions and heart failure hospitalization in primary prevention ICD patients. <i>Eur J Med Res<\/i> 2020; 25: 5, doi:10.1186\/s40001-020-0401-x.","DOI":"10.1186\/s40001-020-0401-x"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Zhou Y, Zhao S, Chen K, Hua W, Su Y, Chen S, et al. Predictive value of rapid-rate non-sustained ventricular tachycardia in the occurrence of appropriate implantable cardioverter-defibrillator therapy. <i>J Interv Card Electrophysiol<\/i> 2020; 57: 473\u2013480, doi:10.1007\/s10840-019-00557-4.","DOI":"10.1007\/s10840-019-00557-4"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Pokorney SD, Miller AL, Chen AY, Thomas L, Fonarow GC, de Lemos JA, et al. Implantable cardioverter-defibrillator use among medicare patients with low ejection fraction after acute myocardial infarction. <i>JAMA<\/i> 2015; 313: 2433\u20132440, doi:10.1001\/jama.2015.6409","DOI":"10.1001\/jama.2015.6409"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Shimizu A, Nitta T, Kurita T, Imai K, Kobayashi Y, Soejima K, et al. Actual conditions of implantable defibrillation therapy over 5 years in Japan. <i>J Arrhythm<\/i> 2012; 28: 263\u2013272.","DOI":"10.1016\/j.joa.2012.03.014"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Greenberg SM, Epstein AE, Deering T, Goldman DS, Ghidina M, Neason C, et al. A comparison of ICD implantations in the United States versus Italy. <i>Pacing Clin Electrophysiol<\/i> 2007; 30(Suppl 1): S143\u2013S146, doi:10.1111\/j.1540-8159.2007.00625.x.","DOI":"10.1111\/j.1540-8159.2007.00625.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kramer DB, Kennedy KF, Noseworthy PA, Buxton AE, Josephson ME, Normand SL, et al. Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: Results from the NCDR. <i>Circ Cardiovasc Qual Outcomes<\/i> 2013; 6: 488\u2013497, doi:10.1161\/CIRCOUTCOMES.111.000054.","DOI":"10.1161\/CIRCOUTCOMES.111.000054"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Zabel M, Willems R, Lubinski A, Bauer A, Brugada J, Conen D, et al. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: Results of the EU-CERT-ICD controlled multicentre cohort study. <i>Eur Heart J<\/i> 2020; 41: 3437\u20133447, doi:10.1093\/eurheartj\/ehaa226.","DOI":"10.1093\/eurheartj\/ehaa226"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Hess PL, Al-Khatib SM, Han JY, Edwards R, Bardy GH, Bigger JT, et al. Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: Does age matter? An analysis of pooled data from 5 clinical trials. <i>Circ Cardiovasc Qual Outcomes<\/i> 2015; 8: 179\u2013186, doi:10.1161\/CIRCOUTCOMES.114.001306.","DOI":"10.1161\/CIRCOUTCOMES.114.001306"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/1\/90_CJ-24-0888\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T03:18:20Z","timestamp":1766805500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/1\/90_CJ-24-0888\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-24-0888","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]},"article-number":"CJ-24-0888"}}